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A previous report indicated that progesterone pretreatment can markedly reduce cadmium (Cd) toxicity in male NAW mice. Therefore we examined
the effects of progesterone pretreatment on Cd toxicity in male Fischer (F344) and Wistar (WF) rats. A single subcutaneous injection of 10 or 30
pmole (CdCI2)/kg proved nonlethal over 24 hr but caused the typical spectrum of testicular lesions in these rats. Moreover, when F344 rats were
pretreated with progesterone (100 mg/kg, sc, at -48, -24, and 0 hr) and then given cadmium (20 pmole CdCI2/kg, 0 hr), this dose of cadmium
proved very toxic, unexpectedly causing 53% mortality. Progesterone pretreatment had no effect on cadmium-induced lethality in WF rats or on tes-
ticular lesions in either strain. Significant elevations in serum lactate dehydrogenase (LDH) activity, indicative of hepatotoxicity, were also observed in
progesterone-pretreated F344 rats given cadmium as compared to rats given Cd alone. Progesterone did not induce increases in hepatic or renal met-
allothionein (MT) and hepatic or testicular MT-I mRNA levels in F344 rats. In contrast, levels of the testicular cadmium-binding protein (TCBP) in prog-
esterone-pretreated F344 rats were doubled. This increase in TCBP provided no protection against cadmium toxicity in the testes. These results
indicate that, in contrast to previously reported data for mice, progesterone pretreatment increased the lethality of cadmium in male F344 rats and
had no effect on cadmium-induced testicular toxicity in F344 and WF rats. - Environ Health Perspect 102(Suppl 3):277-280 (1994).
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Introduction
Although steroid hormones can modify
cadmium toxicity in rodents, very little
mechanistic information about the effect of
these compounds on cadmium-induced
lesions is available. Gunn et al. (1)
reported that estrogen and stilbestrol pro-
tected CD-1 mouse testes against injury
from cadmium, although estrogens did not
modify cadmium accumulation in the
testes (2). Wolkowoski-Tyl and Preston
(3) reported that progesterone pretreat-
ment prevented the necrotizing effects of
cadmium in NAW mouse testes, but corti-
costerone and dexamethasone were without
effect. That study suggested that proges-
terone induced a dimer of cadmium-
thionein ('Cd-bp-D', 19,000 mw) in liver
that may have an important role in resis-
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tance to cadmium-induced testicular
necrosis (3). However, these authors did
not show whether progesterone induced
cadmium-binding proteins in the testes,
and cadmium content in testes was actually
increased by prior progesterone treatment.
Therefore, the basis of the cadmium toler-
ance induced by sex hormones is unclear
and has not been demonstrated in species
other than the mouse. Thus, the current
study examined the effects of progesterone
pretreatment on cadmium toxicity in male
Fischer (F344) and Wistar (WF) rats, and
investigated the induction of cadmium-
binding proteins by progesterone.
Materials and Methods
Animals andTreatment
Adult male Fischer (F344) and Wistar
(WF) rats from the Frederic Cancer
Research and Development Center Animal
Production Area (Frederick, MD), weigh-
ing 300 to 400 g, were used throughout
this study. Progesterone (100 mg/kg), dis-
solved in sesame seed oil, or oil (4 ml/kg)
were injected, sc, for three consecutive
days. Cadmium chloride (CdCl2; 10-30
pmole/kg), dissolved in saline, or saline (4
ml/kg) was injected concomitantlywith the
last injection of progesterone or oil. Rats
were sacrificed by CO2 asphyxia 24 hr after
the last injection and liver, kidney, and
testes were excised.
HistologicalAnalysis ofTissueDamage
Tissues were fixed in 10% neutral buffered
formalin, embedded in paraffin, sectioned,
and stained with hematoxylin and eosin.
One representative section of liver and
both testes and kidneys were examined.
BiochemicalAnalysis
Serum lactate dehydrogenase (LDH) and
blood urea nitrogen (BUN) were assayed
with commercially available kits (Sigma
Chemical Co., St. Louis, MO). Metallo-
thionein (MT) levels were determined in
liver and kidney using the cadmium-
hemoglobin method of Onosaka et al. (4)
as modified by Eaton and Toal (5). The
assay was also used to measure testicular
cadmium-binding protein (TCBP) levels
(6). MT-I mRNA levels were determined
by Northern and slot-blot analysis, which
were carried out as described by Coogan et
al. (7). Relative MT-I mRNA expression
was defined as MT-I mRNA content in
relation to f-actin mRNA content. Tissue
metal concentrations were measured by
atomic absorption spectrometry after acid
digestion.
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Table 1. Cadmium-induced mortality in male F344 andWistarrats: effectof progesterone.
Treatmenta Dead/treated (
F344
Control 0/10 0
Progesterone 0/10 0
Cd(10 pmole/kg) 0/4 0
Cd(20 pmole/kg) 0/6 0
Progesterone +Cd(10 pmole/kg) 0/4 0
Progesterone +Cd (20 pmole/kg) 10/19 53
Wistar
Control 0/4 0
Progesterone 0/4 0
Cd (20 pmol/kg) 0/4 0
Cd (30 pmol/kg) 0/4 0
Progesterone +Cd (20 pmole/kg) 0/10 0
Progesterone +Cd (30 pmole/kg) 1/10 10
aRats were pretreated with progesterone (100 mg/kg, sc, -48,-24 and 0 hrs)and then given Cd (10to 30 pmole/kg, 0 hr). bAssessed 24 hrsafterCdtreatment. Theasterisk indicates a significantdifference(p<0.05)fromcontrol.
Table 2. Effect of progesterone pretreatment on cadmium distribution totestes, liverand kidney in male F344 rats.
Testes, Liver, Kidney,
Treatment ng/organ pg/g pg/g
Control ND 2.1 ± 1.4a 0.6 ±0.6a
Progesterone ND 0.2 ±0.5a 1.1 ±0.4a
Cd 269 ±90a 29.9 ±4.7b 19.7 ±8.5b
Progesterone +Cd 353 ± 118a 23.6 ±5.8b 20.7 ±3.2b
ND, not detected. Rats were pretreated with progesterone (100 mg/kg, sc, -48, -24 and 0 hrs) and then given Cd (20
pmole/kg, 0hr). Values withdiffering superscripts(a,b) indicatesignificant differences(p<0.05) between groups.
Table3. Effect of progesterone pretreatment on serum LDH and BUN levels in male F344and WFrats
[DH,2 BUN,2
Treatment1 Ul mg/dl
F344
Control 82.7 ±39.9a 23.5 ±3.5a
Progesterone 68.4 ± 16.6a 23.8 ±3.7a
Cd 265.9±26.9b 14.8 ±0.6b
Progesterone + Cd 540.1 + 110.7c 15.7 ± 1.5b
Wistar
Control 42.2 ± 10.5a 18.7 ± 1.2a
Progesterone 46.4+8.9a 19.2 ±0.8a
Cd 96.36.5a,b 11.32.5
Progesterone + Cd 175.0 ±76.5b 12.7 ±2.5b
Rats were pretreated with progesterone (100 mg/kg, sc, -48,-24 and 0 hr), then given Cd (20 pmol/kg, 0 hr). Differing
superscripts(a, b,c)indicatesignificant differences(p<0.05) betweengroups.
Statistics
Unless otherwise stated, the data repre-
sent the mean ± SD of four to eight
determinations. Differences between
treatment groups were evaluated statisti-
cally using one-way analysis of variance
(ANOVA) or Duncan's test. Probability
values <0.05 were considered to indicate
significant differences.
Results
A single sc injection of 10 to 30 pmole
Cd/kg 24 hr earlier proved nonlethal but
caused the typical spectrum of testicular
lesions in F344 and WF rats. Cadmium-
induced degeneration of seminiferous
tubules, edematous vasculitis, and hemor-
rhage in stroma were observed in treated
rats. However, in the case ofF344 rats pre-
treated with progesterone (100 mg/kg, sc,
-48, -24, and 0 hr) and then treated with
cadmium (20 pmole/kg, 0 hr), this dose of
cadmium proved extremely toxic, unex-
pectedly causing a 53% mortality rate. On
the other hand, in the case of WF rats,
progesterone did not increase cadmium-
induced lethality (Table 1). Progesterone
pretreatment had little or no effect on cad-
mium-induced testicular lesions in either
F344 orWF rats.
Since progesterone clearly increased the
lethality of cadmium in F344 rats, experi-
ments were performed to determine if the
increase was due to altered toxicokinetics of
cadmium. Progesterone pretreatment had
no significant effect on the accumulation of
testicular, hepatic, or renal cadmium
(Table 2).
Decreased BUN and increases in serum
LDH activity were observed in F344 and
WF rats treated with cadmium (20 pmole
Cd/kg) as compared with untreated rats.
The decreases in BUN seen with cadmium
treatment likely reflect hepatic insufficiency
in the absence of renal damage. The
increases in cadmium-induced serum LDH
in F344 rats was enhanced 2-fold by prog-
esterone pretreatment, indicating an
enhancement ofcadmium-induced hepato-
toxicity (Table 3). In these rats, proges-
terone pretreatment caused extensive
hepatocellular necrosis (not shown).
Progesterone or cadmium alone did not
cause any such hepatic lesions. In the case
ofWF rats, pretreatment with progesterone
partially enhanced the increases in serum
LDH induced by cadmium (20 pmole
Cd/kg) (Table 3).
In F344 rats treated with cadmium,
marked increases in hepatic or renal MT
were observed as compared to control lev-
els. With progesterone pretreatment, simi-
lar cadmium-induced increases were
observed. However, increases in hepatic
MT in F344 rats treated with 20 pmole
Cd/kg following progesterone pretreatment
were less than those in rats treated with
cadmium alone. An increase in hepatic
MT-I mRNA was observed in rats treated
with cadmium, but not in progesterone-
pretreated rats, as compared with controls.
In contrast, a decrease in testicular MT-I
mRNA was observed in rats treated with
cadmium and progesterone as compared
with controls (Table 4).
In contrast to liver and kidney MT,
increases in testicular cadmium-binding
protein (TCBP) in F344 rats treated with
cadmium (20 pmole/kg) were not
observed. On the contrary, levels ofTCBP
in rats treated with cadmium were
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Table 4. Effect of progesterone pretreatment on hepatic
and renal MT, testicular cadmium-binding protein, and
MT mRNA in male F344 rats.
Treatment1 MT, pg/g
orTCBP, pg/organ MT-1 mRNA3 Normalized
Liver
Control 11.9±3.8a 16
Progesterone 8.6 ± 10
Cd 223.2 ±49.8c ND
Kidney
Control 37.1 ±8.1a ND
Progesterone 52.3 ±4.4a ND
Cd 127.7 ±29.7b ND
Progesterone + Cd 153.9 ±22.4b ND
Testes
Control 13.5 ±2.5a 75
Progesterone 34.1 ±1.4b 22
Cd 6.2± 1.5c 36
Progesterone +Cd 8.6 ± 1.1c ND
ND; not determined. Rats were pretreated with proges-
terone (100 mg/kg, sc, -4,-24, and 0 hr, then given Cd
(20 pmole/kg, 0 hr). 2MT levels were determined in liver
and kidney, and TCBP levels were determined in testes.
Values with differing superscripts (a,b,c) indicate signifi-
cantdifferences(p<0.05) between groups.
markedly decreased as compared with
untreated rats. Although progesterone pre-
treatment did not increase hepatic and
renal MT, it doubled levels of TCBP.
However, progesterone pretreatment did
not prevent the reduction of levels of
TCBP seen with 20 pmole/kg cadmium
treatment (Table 4).
Discussion
The results in this study indicate that, in
contrast to previously reported data in the
NAW mouse (3), progesterone pretreat-
ment increased the toxicity ofcadmium in
the F344 rat, as assessed by lethality, and
had no effect on cadmium-induced testicu-
lar toxicity in either F344 or WF rats. It is
suspected that the acute lethal effects of
cadmium are due to necrotic lesions in the
liver (8) and the increased lethality ofcad-
mium in F344 rats appeared to be due to
progesterone potentiation of cadmium
hepatotoxicity. The potentiation of cad-
mium hepatotoxicity has not been reported
in mice pretreated with estrogen (1) or
progesterone (3). On the other hand, dur-
ing pregnancy, a time of high circulating
progesterone levels, mammals are extremely
susceptible to cadmium toxicity (9-12). In
the rat, for example, Parizek (9,10) showed
that a single sc injection of 40 jimole
CdCl2/kg on days 17 to 21 of gestation
resulted in marked degenerative changes of
the placenta and in fetal death in a high
proportion of pregnant rats. Pronounced
necrotic lesions also occur in the maternal
kidney (10-12) and liver (12) ofpregnant
rats exposed to cadmium. Likewise in
humans, multiple pregnancies appear to
predispose women to chronic cadmium
intoxication, such as in itai-itai disease (13)
although any specific role of progesterone
in this disorder is as yet obscure. In the
present study, progesterone appeared to
sensitize the liver to cadmium toxicity, as a
single sc injection at a dose normally toler-
ated (20 pmole Cd/kg) given following
progesterone pretreatment caused extensive
necrotic damage in the liver, a lesion nor-
mally observed only with much higher
doses of cadmium (8). These results indi-
cate that, similar to previously reported
data for pregnant rats (12), progesterone
sensitizes at least one strain of rats to cad-
mium-induced hepatotoxicity.
In contrast to previous results in the
mouse, progesterone pretreatment had no
effect on testicular toxicity in either strain
ofrats. Gunn and Gould (2) had also indi-
cated that attempts to protect the testes of
Wistar rats from cadmium damage by
estrogen pretreatment were not successful.
They speculated that this might be related
to the fact that the testis of the rat was
much more sensitive to antiandrogenic
effects of estrogen than that of the mouse.
Similarly, there may be a difference in sen-
sitivity to progesterone between rat and
mouse.
Wolkowoski-Tyl and Preston (3) sug-
gested that a dimer of cadmium-thionein
('Cd-bp-D', 19,000 mw), induced in liver
by progesterone pretreatment, may have an
important role in resistance to cadmium-
induced testicular necrosis. However, in
this study, progesterone pretreatment had
no effect on hepatic MT and MT-mRNA
levels. Previously, Bracken and Klaassen
(14) reported that sex steroids (j-estradiol,
progesterone, and testosterone) were inef-
fective as inducers of MT in rat hepato-
cytes. From these results, we conclude that
progesterone alone is not even a weak
inducer of hepatic MT in rats. In fact,
progesterone pretreatment actually weak-
ened the induction response ofMT to cad-
mium in the liver. Whether or not this
diminished response to cadmium plays a
role in sensitizing the liver to cadmium
intoxication remains to be established.
Progesterone pretreatment doubled lev-
els of the TCBP as assessed by cadmium
binding, while MT-I mRNA expression
was reduced by almost 70%. Clearly from
these data the levels ofTCBP are not corre-
lated with the levels of MT-I mRNA. This
is further evidence ofthe marked difference
between TCBP and authentic MT
(6,15,16). Beyond this, it is evident that
the increased levels ofTCBP had no major
effect on the testicular toxicity of cad-
mium.
In conclusion, the results ofthis study
indicate that, in contrast to previously
reported data in mice (3), progesterone
pretreatment markedly increased the over-
all toxicity of cadmium in F344 rats, and
had no effect on cadmium-induced testic-
ular toxicity in either F344 or WF rats.
The increased lethality in F344 rats
appeared to be due to progesterone poten-
tiation of cadmium hepatotoxicity, but
further research will be required to fully
define this effect.
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